Skip to main content
SpringerLink
Log in

Effect of Animal Condition and Fluvoxamine on the Result of [18F]N-3-Fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) Nortropane ([18F]FP-CIT) PET Study in Mice

  • Original Article
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

PET (positron emission tomography) is a noninvasive imaging technique, visualizing biological aspects in vivo. In animal models, the result of PET study can be affected more prominently than in humans by the animal conditions or drug pretreatment. We assessed the effects of anesthesia, body temperature, and pretreatment with selective serotonin reuptake inhibitor on the results of [18F]N-3-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane ([18F]FP-CIT) PET in mice.

Methods

[18F]FP-CIT PET of C57BL/6 mice was performed in three different conditions: (1) anesthesia (isoflurane) with active warming (38°C) as a reference; (2) no anesthesia or warming; (3) anesthesia without warming at room temperature. Additional groups of mice pretreated with escalating doses of fluvoxamine (5, 20, 40, 80 mg/kg) were imaged in condition (1). The time activity curve and standardized uptake value of the striatum, cerebral cortex, and bone were compared among these conditions.

Results

In all conditions, radioactivities of the striatum and cortex tended to form a plateau after rapid uptake and washout, but that of bone tended to increase gradually. When anesthetized without any warming, all the mice developed hypothermia and showed reduced bone uptake with slightly increased striatal and cortical uptakes compared to the reference condition. In conditions without anesthesia, striatal and cortical uptakes were reduced, whereas the bone uptake showed no change. Pretreatment with fluvoxamine increased the striatal uptake and striatal specific to cortical non-specific uptake ratio, whereas the bone uptake was reduced.

Conclusion

Anesthesia, body temperature, and fluvoxamine affect the result of [18F]FP-CIT PET in mice by altering striatal and bone uptakes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jones T. The imaging science of positron emission tomography. Eur J Nucl Med. 1996;23(7):807–13.

    Article  PubMed  CAS  Google Scholar 

  2. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur J Nucl Med. 1996;23(2):207–11.

    Article  PubMed  CAS  Google Scholar 

  3. Chatziioannou AF. Molecular imaging of small animals with dedicated PET tomographs. Eur J Nucl Med Mol Imaging. 2002;29(1):98–114. doi:10.1007/s00259-001-0683-3.

    Article  PubMed  Google Scholar 

  4. Tornai MP, Jaszczak RJ, Turkington TG, Coleman RE. Small-animal PET: advent of a new era of PET research. J Nucl Med. 1999;40(7):1176–9.

    PubMed  CAS  Google Scholar 

  5. Budinger TF, Benaron DA, Koretsky AP. Imaging transgenic animals. Annu Rev Biomed Eng. 1999;1:611–48. doi:10.1146/annurev.bioeng.1.1.611.

    Article  PubMed  CAS  Google Scholar 

  6. Cherry SR, Gambhir SS. Use of positron emission tomography in animal research. ILAR J. 2001;42(3):219–32.

    PubMed  CAS  Google Scholar 

  7. Green MV, Seidel J, Vaquero JJ, Jagoda E, Lee I, Eckelman WC. High resolution PET, SPECT and projection imaging in small animals. Comput Med Imaging Graph. 2001;25(2):79–86.

    Article  PubMed  CAS  Google Scholar 

  8. Rao S, Verkman AS. Analysis of organ physiology in transgenic mice. Am J Physiol Cell Physiol. 2000;279(1):C1–C18.

    PubMed  CAS  Google Scholar 

  9. Kleiber M. The fire of life: an introduction to animal energetics. Huntington, NY: R.E. Krieger; 1975.

    Google Scholar 

  10. Booij J, Tissingh G, Winogrodzka A, van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med. 1999;26(2):171–82.

    Article  PubMed  CAS  Google Scholar 

  11. Chaly T, Dhawan V, Kazumata K, Antonini A, Margouleff C, Dahl JR, et al. Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl Med Biol. 1996;23(8):999–1004.

    Article  PubMed  CAS  Google Scholar 

  12. Lundkvist C, Halldin C, Ginovart N, Swahn CG, Farde L. [18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter. Nucl Med Biol. 1997;24(7):621–7.

    Article  PubMed  CAS  Google Scholar 

  13. Pike VW. PET radiotracers: crossing the blood–brain barrier and surviving metabolism. Trends Pharmacol Sci. 2009;30(8):431–40. doi:10.1016/j.tips.2009.05.005.

    Article  PubMed  CAS  Google Scholar 

  14. Giron MC, Portolan S, Bin A, Mazzi U, Cutler CS. Cytochrome P450 and radiopharmaceutical metabolism. Q J Nucl Med Mol Imaging. 2008;52(3):254–66.

    PubMed  CAS  Google Scholar 

  15. Tipre DN, Zoghbi SS, Liow JS, Green MV, Seidel J, Ichise M, et al. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole. J Nucl Med. 2006;47(2):345–53.

    PubMed  CAS  Google Scholar 

  16. Ryu YH, Liow JS, Zoghbi S, Fujita M, Collins J, Tipre D, et al. Disulfiram inhibits defluorination of (18)F-FCWAY, reduces bone radioactivity, and enhances visualization of radioligand binding to serotonin 5-HT1A receptors in human brain. J Nucl Med. 2007;48(7):1154–61. doi:10.2967/jnumed.107.039933.

    Article  PubMed  CAS  Google Scholar 

  17. Matusch A, Meyer PT, Bier D, Holschbach MH, Woitalla D, Elmenhorst D, et al. Metabolism of the A1 adenosine receptor PET ligand [18 F]CPFPX by CYP1A2: implications for bolus/infusion PET studies. Nucl Med Biol. 2006;33(7):891–8. doi:10.1016/j.nucmedbio.2006.07.006.

    Article  PubMed  CAS  Google Scholar 

  18. Bier D, Holschbach MH, Wutz W, Olsson RA, Coenen HH. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18 F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18 F]CPFPX) in rodents and humans. Drug Metab Dispos. 2006;34(4):570–6. doi:10.1124/dmd.105.006411.

    Article  PubMed  CAS  Google Scholar 

  19. Jensen KG, Poulsen HE, Doehmer J, Loft S. Kinetics and inhibition by fluvoxamine of phenacetin O-deethylation in V79 cells expressing human CYP1A2. Pharmacol Toxicol. 1995;76(4):286–8.

    Article  PubMed  CAS  Google Scholar 

  20. Baumann P. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clin Pharmacokinet. 1996;31(6):444–69.

    Article  PubMed  CAS  Google Scholar 

  21. DeVane CL, Gill HS. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design. J Clin Psychiatry. 1997;58 Suppl 5:7–14.

    PubMed  CAS  Google Scholar 

  22. Sihver W, Drewes B, Schulze A, Olsson RA, Coenen HH. Evaluation of novel tropane analogues in comparison with the binding characteristics of [18 F]FP-CIT and [131I]beta-CIT. Nucl Med Biol. 2007;34(2):211–9. doi:10.1016/j.nucmedbio.2006.11.005.

    Article  PubMed  CAS  Google Scholar 

  23. Lee SJ, Oh SJ, Chi DY, Kang SH, Kil HS, Kim JS, et al. One-step high-radiochemical-yield synthesis of [18 F]FP-CIT using a protic solvent system. Nucl Med Biol. 2007;34(4):345–51. doi:10.1016/j.nucmedbio.2007.02.007.

    Article  PubMed  CAS  Google Scholar 

  24. Kim JS, Lee JS, Im KC, Kim SJ, Kim SY, Lee DS, et al. Performance measurement of the microPET focus 120 scanner. J Nucl Med. 2007;48(9):1527–35. doi:10.2967/jnumed.107.040550.

    Article  PubMed  Google Scholar 

  25. Gordon CJ. Temperature regulation in laboratory rodents. Cambridge England ; New York, NY, USA: Cambridge University Press; 1993.

  26. Eckenhoff RG, Fagan D. Inhalation anaesthetic competition at high-affinity cocaine binding sites in rat brain synaptosomes. Br J Anaesth. 1994;73(6):820–5.

    Article  PubMed  CAS  Google Scholar 

  27. Goodman MM, Kilts CD, Keil R, Shi B, Martarello L, Xing D, et al. 18 F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol. 2000;27(1):1–12.

    Article  PubMed  CAS  Google Scholar 

  28. Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, et al. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res. 1999;849(1–2):85–96.

    Article  PubMed  CAS  Google Scholar 

  29. Votaw J, Byas-Smith M, Hua J, Voll R, Martarello L, Levey AI, et al. Interaction of isoflurane with the dopamine transporter. Anesthesiology. 2003;98(2):404–11.

    Article  PubMed  CAS  Google Scholar 

  30. Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology. 1993;79(4):795–807.

    Article  PubMed  CAS  Google Scholar 

  31. Welch MJ, Katzenellenbogen JA, Mathias CJ, Brodack JW, Carlson KE, Chi DY, et al. N-(3-[18 F]fluoropropyl)-spiperone: the preferred 18 F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor. Int J Rad Appl Instrum B. 1988;15(1):83–97.

    PubMed  CAS  Google Scholar 

  32. Bondy B, Spellmann I. Pharmacogenetics of antipsychotics: useful for the clinician? Curr Opin Psychiatry. 2007;20(2):126–30. doi:10.1097/YCO.0b013e328017f69f.

    Article  PubMed  Google Scholar 

  33. Kobayashi K, Yamamoto T, Chiba K, Tani M, Shimada N, Ishizaki T, et al. Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4. Drug Metab Dispos. 1998;26(8):818–21.

    PubMed  CAS  Google Scholar 

  34. Tateishi T, Krivoruk Y, Ueng YF, Wood AJ, Guengerich FP, Wood M. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation. Anesth Analg. 1996;82(1):167–72.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This study was supported by a grant (07–405) from the Asan Institute for Life Sciences, Seoul, Korea

Conflict of Interest Disclosure

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 138-736, South Korea

    Kwang-Ho Shin, Sang Ju Lee, Seung Jun Oh & Jae Seung Kim

  2. The UNIST Central Research Facilities Center, Ulsan National Institute of Science and Technology, Ulsan, 689-798, South Korea

    Su-A Park

  3. Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, PA, 15213, USA

    Seog-Young Kim

  4. Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-2dong, Songpa-gu, Seoul, 138-736, Korea

    Jae Seung Kim

Authors
  1. Kwang-Ho Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Su-A Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seog-Young Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sang Ju Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seung Jun Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jae Seung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jae Seung Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin, KH., Park, SA., Kim, SY. et al. Effect of Animal Condition and Fluvoxamine on the Result of [18F]N-3-Fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) Nortropane ([18F]FP-CIT) PET Study in Mice. Nucl Med Mol Imaging 46, 27–33 (2012). https://doi.org/10.1007/s13139-011-0117-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-011-0117-5

Keywords

Search

Navigation